U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of Inspections and Investigations
  5. OII Inspectorates
  6. Office of Bioresearch Monitoring Inspectorate (OBMI)
  7. Eric Pittman
  1. Office of Bioresearch Monitoring Inspectorate (OBMI)

Eric S. Pittman MBA
Leadership Role

Eric S. Pittman

Eric S. Pittman is the Program Division Director for Bioresearch Monitoring West (BIMO-W) which is part of the Office of Regulatory Affairs’ (ORA) Office of Bioresearch Monitoring Operations (OBIMO) in the Food and Drug Administration (FDA). He is responsible for a group of professional investigators, supervisors, and support staff who work with each of FDAs product centers performing inspections of clinical and non-clinical trials, post-market adverse drug experiences, and risk evaluation and mitigation strategies. In addition to his division, Mr. Pittman is the U.S. Delegate to the Organisation for Economic Cooperation and Development (OECD) Working Party on Good Laboratory Practices.

Mr. Pittman previously led the Division of Human and Animal Food Domestic Operations in ORA Headquarters. Prior to that, he was a supervisory investigator in the Chicago District Office where he won the 2011 ORA Supervisory Investigator of the Year. He has also worked as a field investigator in the Chicago District and the Detroit District offices.

Mr. Pittman studied pharmacy and radiation physics in his undergraduate work at Purdue University. He also holds a Master of Business Administration from Youngstown State University.
 

Back to Top